Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study
Abstract
Adiponectin, a novel adipocytokine produced exclusively in the adipose tissue, plays a major role in the development of metabolic syndrome, type 2 diabetes mellitus, and related cardiovascular (CV) diseases. However, information is scant regarding the association of adiponectin with measures of CV risk in young adults. This aspect was examined in a biracial (black-white) community-based sample of 1153 individuals (mean age, 36.2 years; 70% white, 43% male) who participated in the Bogalusa Heart Study. Adiponectin levels showed race (white > black, P < .0001) and sex (female > male, P < .0001) differences, and correlated significantly in a beneficial manner to measures of obesity (body mass index, waist circumference, and abdominal height), mean arterial blood pressure, lipoprotein variables (low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides), measures of glucose homeostasis (insulin, glucose, homeostasis model assessment of insulin resistance [HOMA-IR]), and uric acid, after adjusting for age, race, sex, and cigarette smoking. In multivariate analysis that used either body mass index or abdominal height as a measure of general and visceral adiposity in 2 separate models, HOMA-IR was the major contributor explaining 18.4% and 18.1% of the variance, respectively. There was a significant interaction between abdominal height and HOMA-IR on adiponectin level in that the inverse association between adiponectin and insulin resistance was pronounced at higher level of visceral adiposity. Furthermore, adiponectin levels decreased with increasing number of metabolic syndrome risk factors defined by the National Cholesterol Education Program Adult Treatment Panel III (P for trend <.0001). Moreover, adiponectin levels were low among those with positive parental histories of coronary heart disease (P = .03), hypertension (P = .04), and type 2 diabetes mellitus (P = .01), considered as surrogate measures of risk. These findings, by showing an inverse association of adiponectin with insulin resistance, visceral adiposity, and related metabolic syndrome, and also with positive parental histories of coronary heart disease, hypertension, and type 2 diabetes mellitus, underscore the value of adiponectin in CV and type 2 diabetes mellitus risk assessments in young adults.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Clinical studies have established correlations between plasma adiponectin levels and various aspects and severity of heart failure.
“First, an important pathophysiological contribution was suggested by the recent explosion in the number of clinical studies that have established correlations between plasma adiponectin levels and various aspects and severity of heart failure (107, 113, 143, 166, 172, 183, 198, 209, 251, 275, 282, 286, 303, 312, 366).”
From Cardiac remodeling in obesity (2008) · cites this paper as [275]
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · see citing works
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915 · see citing works
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,555 · see citing works
Banting lecture 1988. Role of insulin resistance in human disease.
Reaven, G. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,801 · see citing works
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541 · see citing works
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S. P., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,238 · see citing works
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176 · see citing works
Pouliot, M.-C., Despres, J., Lemieux, S., Moorjani, S., Bouchard, C., Tremblay, A., Nadeau, A., & Lupien, P. (1994) · American Journal of Cardiology · doi:10.1016/0002-9149(94)90676-9 · Cited by 2,238 · see citing works
Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,081 · see citing works
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,762 · see citing works
Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2094 · Cited by 1,659 · see citing works
Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483 · see citing works
Association of Hypoadiponectinemia With Coronary Artery Disease in Men
Kumada, M., Kihara, S., Sumitsuji, S., Kawamoto, T., Matsumoto, S., Ouchi, N., Arita, Y., Okamoto, Y., Shimomura, I., Hiraoka, H., et al. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000048856.22331.50 · Cited by 1,419 · see citing works
Adiponectin and Metabolic Syndrome
Matsuzawa, Y., Funahashi, T., Kihara, S., & Shimomura, I. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000099786.99623.ef · Cited by 1,203 · see citing works
Minireview: The Adipocyte—At the Crossroads of Energy Homeostasis, Inflammation, and Atherosclerosis
Rajala, M. W., & Scherer, P. E. (2003) · Endocrinology · doi:10.1210/en.2003-0580 · Cited by 1,190 · see citing works
Adiponectin and development of type 2 diabetes in the Pima Indian population
Lindsay, R. S., Funahashi, T., Hanson, R. L., Matsuzawa, Y., Tanaka, S., Tataranni, P. A., Knowler, W. C., & Krakoff, J. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09335-2 · Cited by 1,094 · see citing works
Adiponectin Expression From Human Adipose Tissue
Kern, P. A., Di Gregorio, G. B., Lu, T., Rassouli, N., & Ranganathan, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1779 · Cited by 875 · see citing works
Facchini, F. (1991) · JAMA · doi:10.1001/jama.1991.03470210076036 · Cited by 860 · see citing works
Androgens Decrease Plasma Adiponectin, an Insulin-Sensitizing Adipocyte-Derived Protein
Nishizawa, H., Shimomura, I., Kishida, K., Maeda, N., Kuriyama, H., Nagaretani, H., Matsuda, M., Kondo, H., Furuyama, N., Kihara, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2734 · Cited by 837 · see citing works
Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndrome
TRUJILLO, M. E., & Scherer, P. E. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01426.x · Cited by 764 · see citing works
Matsuzawa, Y., Funahashi, T., & Nakamura, T. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07793.x · Cited by 601 · see citing works
Plasma Adiponectin Concentrations Predict Insulin Sensitivity of Both Glucose and Lipid Metabolism
Tschritter, O., Fritsche, A., Thamer, C., Haap, M. M., Shirkavand, F., Rahe, S., Staiger, H., Maerker, E., Häring, H. U., & Stümvoll, M. (2003) · Diabetes · doi:10.2337/diabetes.52.2.239 · Cited by 585 · see citing works
DIABETES INCIDENCE IN PIMA INDIANS: CONTRIBUTIONS OF OBESITY AND PARENTAL DIABETES1
KNOWLER, W. C., PETTITT, D. J., SAVAGE, P. J., & BENNETT, P. H. (1981) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113079 · Cited by 561 · see citing works
Adiponectin and the Development of Type 2 Diabetes
Duncan, B. B., Schmidt, M. I., Pankow, J. S., Bang, H., Couper, D. J., Ballantyne, C. M., Hoogeveen, R. C., & HEISS, G. M. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2473 · Cited by 323 · see citing works
Family history of heart attack as an independent predictor of death due to cardiovascular disease.
Barrett-Connor, E. L., & Khaw, K. (1984) · Circulation · doi:10.1161/01.cir.69.6.1065 · Cited by 307 · see citing works
Plasma Adiponectin Concentrations in Children: Relationships with Obesity and Insulinemia
Stefan, N., Bunt, J. C., Salbe, A. D., Funahashi, T., Matsuzawa, Y., & Tataranni, P. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020694 · Cited by 290 · see citing works
Bacha, F. F., Saad, R. J., Gungor, N., & Arslanian, S. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.547 · Cited by 278 · see citing works
Kazumi, T., Kawaguchi, A. T., Sakai, K., Hirano, T., & Yoshino, G. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.971 · Cited by 274 · see citing works
Discrimination Between Obesity and Insulin Resistance in the Relationship With Adiponectin
Abbasi, F., Chu, J. W., Lamendola, C. A., McLaughlin, T., Hayden, J. M., Reaven, G. M., & Reaven, P. D. (2004) · Diabetes · doi:10.2337/diabetes.53.3.585 · Cited by 246 · see citing works
Côté, M., Mauriège, P., Bergeron, J., Alméras, N., Tremblay, A., Lemieux, I., & Després, J.-P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1711 · Cited by 230 · see citing works
Facchini, F. (1991) · JAMA · doi:10.1001/jama.266.21.3008 · Cited by 204 · see citing works
Sjöström, L. (1991) · PubMed · Cited by 182 · see citing works
The role of fibric acids in atherosclerosis
Fruchart, J., Staels, B., & Duriez, P. (2001) · Current Atherosclerosis Reports · doi:10.1007/s11883-001-0015-x · Cited by 170 · see citing works
Hulthe, J., Hultén, L. M., & Fagerberg, B. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00313-5 · Cited by 153 · see citing works
Simple anthropometric indices associated with ischemic heart disease
Kahn, H. S., Austin, H. D., Williamson, D. F., & Arensberg, D. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(96)00113-8 · Cited by 143 · see citing works
Familial Clustering of Insulin Sensitivity
Martin, B. C., Warram, J. H., ROSNER, B. A., Rich, S. S., Soeldner, J. S., & Królewski, A. S. (1992) · Diabetes · doi:10.2337/diab.41.7.850 · Cited by 141 · see citing works
Pellmé, F., Smith, U., Funahashi, T., Matsuzawa, Y., Brekke, H. K., Wiklund, O., Taskinen, M., & Jansson, P. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1182 · Cited by 134 · see citing works
Steffes, M. W., Gross, M. D., Schreiner, P. J., Yu, X., Hilner, J. E., Gingerich, R. L., & Jacobs, D. R. (2004) · Annals of Epidemiology · doi:10.1016/j.annepidem.2003.10.006 · Cited by 111 · see citing works
Adipocytokines and VLDL Metabolism
Ng, T. W., Watts, G. F., Farvid, M. S., Chan, D. C., & Barrett, P. H. R. (2005) · Diabetes · doi:10.2337/diabetes.54.3.795 · Cited by 108 · see citing works
Førde, O. H., & Thelle, D. S. (1977) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112375 · Cited by 70 · see citing works
Chen, W., Srinivasan, S. R., Elkasabany, A., & Berenson, G. S. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00025-8 · Cited by 69 · see citing works
Self-citationFamilial clustering of insulin sensitivity
Martin, B. C., Warram, J. H., Rosner, B., et al. (1992) · Diabetes · doi:10.2337/diabetes.41.7.850 · Cited by 49 · see citing works
Morrison, J. A. (1983) · JAMA · doi:10.1001/jama.250.14.1860 · Cited by 44 · see citing works
Greenlund, K. J., Valdez, R. A., Bao, W., Wattigney, W. A., Srinivasan, S. R., & Berenson, G. S. (1997) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40098-9 · Cited by 29 · see citing works
Self-citationGreenlund, K. J., Valdez, R. A., Bao, W., et al. (1997) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199704000-00005 · Cited by 19 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Packard, R. R. S., & Libby, P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097360 · Cited by 925 · see citing works
Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736 · see citing works
Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer
Vona-Davis, L. C., Howard-McNatt, M. M., & Rose, D. P. (2007) · Obesity Reviews · doi:10.1111/j.1467-789x.2007.00396.x · Cited by 260 · see citing works
Gottlieb, A. B., Chao, C. C., & Dann, F. J. (2008) · Journal of Dermatological Treatment · doi:10.1080/09546630701364768 · Cited by 219 · see citing works
Adiponectin Levels and the Risk of Hypertension
Kim, D. H., Kim, C., Ding, E. L., Townsend, M. K., & Lipsitz, L. A. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01453 · Cited by 164 · see citing works
Visceral Adipose Tissue Inflammation Accelerates Atherosclerosis in Apolipoprotein E–Deficient Mice
Öhman, M. K., Shen, Y., Obimba, C. I., Wright, A. P., Warnock, M., Lawrence, D. A., & Eitzman, D. T. (2008) · Circulation · doi:10.1161/circulationaha.107.717595 · Cited by 138 · see citing works
Psoriasis and metabolic syndrome
Takahashi, H., & Iizuka, H. (2012) · Journal of dermatology (Print) · doi:10.1111/j.1346-8138.2011.01408.x · Cited by 75 · see citing works
Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis
Dong, S., Wang, Z., Shen, K., & Chen, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.629666 · Cited by 124 · see citing works
Johnston, C. S., Beezhold, B., Mostow, B., & Swan, P. D. (2007) · Journal of Nutrition · doi:10.1093/jn/137.7.1757 · Cited by 112 · see citing works
Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain
Sabio, J. M., Zamora‐Pasadas, M., Jiménez‐Jáimez, J., Albadalejo, F., Vargas‐Hitos, J. A., del Águila, M. M. R., Hidalgo-Tenorio, C., González-Gay, M. Á., & Alonso, J. (2008) · Lupus · doi:10.1177/0961203308093554 · Cited by 97 · see citing works
Adiponectin circulating levels: A new emerging biomarker of cardiovascular risk
Giannessi, D., Maltinti, M., & Ry, S. D. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.014 · Cited by 96 · see citing works
Oikonen, M., Wendelin‐Saarenhovi, M., Lyytikäinen, L., Siitonen, N., Loo, B.-M., Jula, A., Seppälä, I., Saarikoski, L. A., Lehtimäki, T. J., Hutri‐Kähönen, N., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.036 · Cited by 85 · see citing works
What is the best biomarker for metabolic syndrome diagnosis?
Falahi, E., Rad, A., & Roosta, S. (2013) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2013.06.014 · Cited by 70 · see citing works
Phillips, S. A., Ciaraldi, T. P., Oh, D. K., Savu, M. K., & Henry, R. R. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90359.2008 · Cited by 60 · see citing works
Preatherosclerosis and Adiponectin Subfractions in Obese Adolescents
Mangge, H., Almer, G., Haj‐Yahya, S., Pilz, S., Gasser, R. N. A., Möller, R., & Horejsi, R. (2008) · Obesity · doi:10.1038/oby.2008.439 · Cited by 59 · see citing works
Zhang, Y., Kent, J. W., Olivier, M., Ali, O., Cerjak, D., Broeckel, U., Abdou, R., Dyer, T. D., Comuzzie, A. G., Curran, J. E., et al. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-14 · Cited by 44 · see citing works
Bang, O. Y., Saver, J. L., Liebeskind, D. S., Pineda, S., Yun, S. W., & Ovbiagele, B. I. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.03.033 · Cited by 42 · see citing works
Simão, A. N. C., Lozovoy, M. A. B., & Dichi, I. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.723694 · Cited by 41 · see citing works
Kitagawa, K., Miwa, K., Okazaki, S., Sakaguchi, M., & Mochizuki, H. (2015) · European Journal of Neurology · doi:10.1111/ene.12915 · Cited by 33 · see citing works
Bauman, W. A. (2009) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2009.03430.x · Cited by 34 · see citing works
Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome
Mk, G., Dutta, M., & Mahalle, N. P. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.91206 · Cited by 32 · see citing works
Saely, C. H., Risch, L., Hoefle, G., Rein, P., Muendlein, A., Marte, T., Aczél, S., Langer, P. H., & Drexel, H. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.04.029 · Cited by 31 · see citing works
Nguyen, Q. M., Srinivasan, S. R., Xu, J., Chen, W., & Berenson, G. S. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.14 · Cited by 31 · see citing works
Self-citationGenelhu, V. A., Celoria, B. M. J., Duarte, S. F. P., Cabello, P. H., & Francischetti, E. A. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2008.09.009 · Cited by 29 · see citing works
Toprak, D., Toprak, A. C., Chen, W., Xu, J. H., Srinivasan, S. R., & Berenson, G. S. (2010) · Obesity · doi:10.1038/oby.2010.75 · Cited by 28 · see citing works
Self-citationStern, N., Osher, E., & Greenman, Y. (2007) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2007.07297.x · Cited by 27 · see citing works
Pharmacological modulation of vascular inflammation in atherothrombosis
Caterina, R. D., Massaro, M., Scoditti, E., & Carluccio, M. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05784.x · Cited by 23 · see citing works
Sung, S., Chuang, S., Sheu, W. H., Lee, W., Chou, P., & Chen, C.-H. (2008) · Hypertension Research · doi:10.1291/hypres.31.633 · Cited by 23 · see citing works
Adiponectinemia Controls Pro-Angiogenic Cell Therapy
Eren, P., Camus, S. M., Matrone, G., Ebrahimian, T. G., François, D., Tedgui, A., Silvestre, J., & Blanc‐Brude, O. (2009) · Stem Cells · doi:10.1002/stem.219 · Cited by 22 · see citing works
Bidulescu, A., Choudhry, S., Musani, S., Buxbaum, S., Liu, J.-K., Rotimi, C., Wilson, J. G., Taylor, H., & Gibbons, G. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00022 · Cited by 14 · see citing works
Francischetti, E. A., Celoria, B. M. J., Duarte, S. F. P., da Silva, E. G., Santos, I. J., Cabello, P. H., & Genelhu, V. A. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.011 · Cited by 20 · see citing works
Insights Into the Controversial Aspects of Adiponectin in Cardiometabolic Disorders
Francischetti, E. A., Dezonne, R. S., Pereira, C. M., Martins, C. J. D. M., Celoria, B. M. J., de Oliveira, P. A. C., & de Abreu, V. G. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1239-4349 · Cited by 19 · see citing works
Impact of Adiponectin Overexpression on Allergic Airways Responses in Mice
Verbout, N. G., Benedito, L. A. P., Williams, A. S., Kasahara, D. I., Wurmbrand, A. P., Si, H., Halayko, A. J., Hug, C., & Shore, S. A. (2013) · Journal of Allergy · doi:10.1155/2013/349520 · Cited by 17 · see citing works
Metabolic Syndrome: Epidemiology, Pathophysiology, and Nutrition Intervention
Dichi, I., Simão, A. N. C., Vannucchi, H., Curi, R., & Calder, P. C. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/584541 · Cited by 17 · see citing works
Francischetti, E. A., Celoria, B. M. J., Francischetti, A., & Genelhu, V. A. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.289 · Cited by 15 · see citing works
Regression of corneal neovascularization: Adiponectin versus bevacizumab eye drops
Baradaran‐Rafii, A., Ashnagar, A., Keshel, S. H., Jabbehdari, S., & Baradaran-Rafii, G. (2019) · European Journal of Ophthalmology · doi:10.1177/1120672119874947 · Cited by 15 · see citing works
Insulin resistance in young, lean male subjects with essential hypertension
Penesová, A., Cizmárová, E., Belan, V., Blazicek, P., Imrich, R., Vlček, M., Vigas, M., Selko, D., Koška, J., & Rádiková, Ž. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.72 · Cited by 14 · see citing works
Simão, A. N. C., Lozovoy, M. A. B., Simão, T. N. C., Morimoto, H. K., & Dichi, I. (2011) · Journal of Nutrition and Metabolism · doi:10.1155/2012/418094 · Cited by 11 · see citing works
Park, C. S., Ihm, S., Park, H., Shin, W., Kim, P.-J., Chang, K., Kim, H.-Y., Youn, H., Chung, W.-S., Seung, K. B., et al. (2011) · Korean Circulation Journal · doi:10.4070/kcj.2011.41.4.198 · Cited by 10 · see citing works
Chédid, R., Zoghbi, F., Halaby, G., & Gannagé-Yared, M.-H. (2011) · PubMed · doi:10.3275/7350 · Cited by 8 · see citing works
Wardaningsih, E., Miida, T., Seino, U., Fueki, Y., Ito, M., Nagasaki, K., Kikuchi, T., Uchiyama, M., Hirayama, S., Hanyu, O., et al. (2008) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2008.007237 · Cited by 7 · see citing works
Bundy, V. L., Johnson, M. H., Gutin, B., Zhu, H., Stallmann-Jorgensen, I. S., & Dong, Y. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.036 · Cited by 7 · see citing works
Morrison, J. A., Glueck, C. J., Daniels, S. R., & Wang, P. (2011) · Obesity · doi:10.1038/oby.2011.126 · Cited by 6 · see citing works
The relationship between adiponectin and blood pressure in premenopausal and postmenopausal women
Kotani, K., Jt, C., & Taniguchi, N. (2011) · Clinical and investigative medicine · doi:10.25011/cim.v34i3.15184 · Cited by 6 · see citing works
Nauru and Mauritius: Barometers of a Global Diabetes Epidemic
Zimmet, P. (2010) · Hamdan Medical Journal · doi:10.2174/1996327001003020078 · Cited by 6 · see citing works
[Psoriasis and cardiovascular disease].
Torres, T. R., Sales, R., Vasconcelos, C., & Selores, M. (2013) · PubMed · Cited by 5 · see citing works
Rajkumar, H., Annapurna, V., Damayanthi, K., & Radhakrishna, K. (2010) · Hamdan Medical Journal · doi:10.2174/1996327001003020110 · Cited by 4 · see citing works
Singhal, S., CHAUHAN, K., Tripathi, A., & CHOUDHARY, R. (2024) · MAEDICA – a Journal of Clinical Medicine · doi:10.26574/maedica.2024.19.3.494 · Cited by 3 · see citing works
Genelhu, V. A., Francischetti, E. A., Duarte, S. F., Celoria, B. M. J., Oliveira, R. C., Cabello, P. H., & Pimentel, M. M. G. (2010) · Genetics and Molecular Research · doi:10.4238/vol9-3gmr819 · Cited by 3 · see citing works
Is there any role of glucose-6-phosphate dehydrogenase in obesity induced metabolic disorder
Sankhla, M., Mathur, K., & Rathor, J. S. (2012) · Health · doi:10.4236/health.2012.412a219 · Cited by 3 · see citing works
Kajbafi, M., Saki, A., Afsharmanesh, M. R., & Shishehbor, F. (2015) · Journal of Obesity and Metabolic Research · doi:10.4103/2347-9906.156529 · Cited by 2 · see citing works
Evolution of Metabolic Syndrome from Childhood
Chen, W. (2011) · Springer eBooks · doi:10.1007/978-94-007-1451-9_4 · Cited by 1 · see citing works
Self-citationHoffmann, K., Bryl, W., Strażyńska, A., Miczke, A., Cymerys, M., Kramer, L., & Pupek‐Musialik, D. (2008) · Arterial Hypertension · Cited by 1 · see citing works
Visfatin and adiponectin as early markers of atherosclerosis in type 2 diabetes mellitus
Zakaria, I., Rizk, M. N., Rakha, M., & El‐Shehaby, A. (2013) · The Egyptian Journal of Internal Medicine · doi:10.7123/01.ejim.0000433121.61723.90
Physical Activity, Body Fat, and Endothelial Function in Mexican American Male Adoloscents
Winokur, E. J. (2012) · UA Campus Repository (The University of Arizona)
Adiponectin and Risk Factors for Cardiovascular Disease and Type 2 Diabetes in Black and White Youth
Jessup, A. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/kjm2-9k14
Impact Of Adiponectin Overexpression On Allergic Airways Responses In Mice
Verbout, N. G., Hug, C., Si, H., & Shore, S. A. (2010) · doi:10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a5189
Sharma, S. D., Acharya, M., & Yadav, M. K. (2021) · Journal of Datta Meghe Institute of Medical Sciences University · doi:10.4103/jdmimsu.jdmimsu_477_21
Black–White Divergence Influencing Impaired Fasting Glucose and Type 2 Diabetes Mellitus
Nguyen, Q. M., Srinivasan, S. R., & Berenson, G. S. (2011) · Springer eBooks · doi:10.1007/978-94-007-1451-9_5
Self-citation
- Authors
- Patel, D. A., Srinivasan, S. R., Xu, J.-H., Chen, W., & Berenson, G. S.
- Affiliations
- Tulane University (US)
- Corresponding author
- Berenson, Gerald S.
- ORCID
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2006-11
- Volume
- 55
- Issue
- 11
- Pages
- 1551-1557
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W1989310165
- Cited by
- 62
- References
- 45
- Citations by year
- 2024: 1 · 2021: 2 · 2020: 2 · 2019: 2 · 2015: 2 · 2014: 1 · 2013: 6 · 2012: 7
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG16592, R01AG016592)
- National Heart, Lung, and Blood Institute (HL 38 844)
- Topics
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- adiponectin, cardiovascular risk, young adults, insulin resistance, visceral fat, metabolic syndrome, type 2 diabetes, coronary artery disease, hypertension, racial differences, sex differences, Bogalusa Heart Study
- MeSH terms
- Adult, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Female, Humans, Insulin, Insulin Resistance, Lipoproteins, Male, Sex Factors, Uric Acid, Cohort Studies, Body Mass Index, Linear Models, Metabolic Syndrome, Adiposity, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review